author

Dr. Ajit Kumar

Dr. Ajit Kumar is a health educator, medical content reviewer, and founder of Medimadad, an evidence-based health education platform. He holds an MD (Medicine) degree and an MA (Psychology), bringing together medical knowledge and behavioral science to promote informed health decisions. His areas of focus include diabetes and metabolic health, men's health and sexual wellness, preventive healthcare, healthy aging, health psychology, and public health education. Through Medimadad, he is committed to improving health literacy by translating complex medical information into practical, accessible, and evidence-based educational content. Dr. Kumar is passionate about leveraging technology, digital health tools, and public health communication to empower individuals to make informed choices for long-term health and well-being.

Hantavirus Cruise Ship Outbreak 2026: 8 Cases, 3 Deaths – Symptoms and What You Must Know

🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author  |  Editorial Policy A luxury cruise ship has become the center of a global health alert. On May 2, 2026, the World Health Organization issued an emergency disease outbreak notice after a cluster of hantavirus infections was […]

Why Most Indians Are Severely Omega-3 Deficient – And What It Is Doing to Your Heart, Brain, and Joints

🦺Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author  |  Editorial Policy Most people have heard that omega-3 fatty acids are good for you. Far fewer realise just how profoundly their absence damages the brain and heart — or how widespread deficiency has become, particularly […]

Survodutide: The New Weight Loss Drug That Could Beat Ozempic and Zepbound

🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author  |  Editorial Policy A new weight loss drug is generating some of the most striking clinical trial results ever seen in the field of obesity medicine. Survodutide — developed by Boehringer Ingelheim and Zealand Pharma — produced […]

About UsContact UsMedical DisclaimerEditorial PolicyAffiliate DisclosureDisclaimerPrivacy Policy